Serum immunoinflammation-related protein complexes discriminate between inflammatory bowel disease and colorectal cancer.
Y H SunJ LiH J ShuZhili LiJ M QianPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2019)
Serum IIRPCs can be used to discriminate IBD from CRC and may also be associated with early screening of colitis-associated cancer.